A process for the preparation of low molecular weight heparin from normal heparin

• 1. 一种低分子量肝素修饰的骨靶向脂质体及其制备方法 [P] . 中国专利： CN111001011B . 2021.07.20
• 2. 一种超低分子量肝素钠及其制备方法 [P] . 中国专利： CN112175109A . 2021-01-05
• 3. Process for the preparation of low molecular weight heparins by depolymerization of normal heparin [P] . DK172798B1 . 1999-07-19

  机译： 普通肝素解聚制备低分子量肝素的方法

• 4. Sodium salt of heparin depolymerised, process for the preparation of a fraction of heparin, process for the preparation of a low molecular weight heparin, and pharmaceutical composition. [P] . BR9401920A . 1994-11-29

  机译： 肝素钠盐解聚，肝素级分的制备方法，低分子量肝素的制备方法和药物组合物。

• 5. Process for manufacturing low molecular weight heparins by depolymerization of normal heparin [P] . 欧洲知识产权局专利： EP0101141A3 . 1985-05-22

  机译： 通过普通肝素解聚生产低分子量肝素的方法

• 1. Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE [J] . CHEN Li-ying, YING Ke-jing, HONG Wu-jun, 浙江大学学报（英文版）（B辑：生物医学和生物技术） . 2005,第012期
• 2. Combined effect of Traditional Chinese Medicine decoction and low-molecular-weight heparin calcium on the postoperative deep venous thrombosis in patients with lower limb fracture [J] . 张惠煊, 马翰斐, 袁杰 世界中西医结合杂志（英文） . 2015,第001期
• 3. Efficacy and Safety of Low Molecular Weight Heparin Prophylaxis for Venous Thromboembolism Following Lumbar Decompression Surgery [J] . Zhi-jian Sun, Xiang Li, Yu Zhao, 中国医学科学杂志（英文版） . 2011,第004期
• 4. Astrocytic effect of low molecular weight heparin-superoxide dismutase conjugate in interleukin-6 overexpressing mice following local cerebral ischemia [J] . Yizhao Li, Guixiang Cui, Qingde Wang, 中国神经再生研究（英文版） . 2009,第002期
• 5. Treatment of PNH hemolytic crisis with heparin or low-molecular weight heparin by its dual (anti-complement and anti-coagulant) activity [C] . Chikashi YOSHIDA, Yasushi OHKOSHI, Yuichi HASEGAWA, International Symposium on PNH and Related Disorders . 2003
• 6. Synthesis and characterization of sugar based low molecular weight gelators and the preparation of chiral sulfinamides. [D] . Mangunuru, Hari Prasad Reddy. 2014
• 7. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): Preparation and characterization [O] . Li-Chien Chang, Hsiao-Feng Lee, ZhiQiang Yang, 2001
• 8. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): Preparation and characterization [O] . Chang, Li-Chien, Lee, Hsiao-Feng, Yang, ZhiQiang, 2001

• 1. Studies of Oral Preparation of Low Molecular Weight Heparin [J] . Hui-Fei Cui Tian-Min ZhangDepartment of Biochemical Pharmaceutics Shandong Medical University Jinan 250012Supported by National Natural Scienec Foundation of China . 中国药学：英文版 . 1995,第1期
• 2. 酶法制备低分子量肝素及其活性研究 [C] . 刘亚梅 ,何书英 ,吴梧桐 . 沪、苏、闽暨全军生物技术药物研讨会 . 2007
• 3. 择期PCI术中应用低分子量肝素与普通肝素对血浆抗-Xa活性及ACT影响的对比研究 [A] . 王乾一 . 2006